4.7 Article

The difluoromethylenesulfonic acid group as a monoanionic phosphate surrogate for obtaining PTP1B inhibitors

期刊

BIOORGANIC & MEDICINAL CHEMISTRY
卷 10, 期 7, 页码 2309-2323

出版社

PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/S0968-0896(02)00062-7

关键词

-

向作者/读者索取更多资源

Three peptides, 7-9, bearing sulfono(difluoromethyl)phenylalanine (F(2)Smp,2), a nonhydrolyzable, monoanionic phosphotyrosine mimetic, were prepared and evaluated as PTP1B inhibitors. The most effective inhibitor was the nonapeptide. ELEF(F(2)Smp)MDYE-NH2. (9) which exhibited a K-i of 360 nM. A comparison of F-2-Smp-bearing peptides 7 [DADE(F(2)Smp)LNH2. K-i=3.4 muM] and 8 [EEDE(F(2)Smp)LNH2. K-i=0.74 muM] with their phosphono(difluoromethyl)phenylalanine (F(2)Pmp)-bearing analogues indicated that F(2)Smp is not as effective a pTyr mimetic as F(2)Pmp by 100- to 130-fold. Although F(2)Smp is not as effective as F(2)Pmp, a comparison of peptide 7 with analagous peptides bearing other monoanionic pTyr mimetics recently reported in the literature indicates that F(2)Smp is about 65-fold more effective than any other non-hydrolyzable, monanionic pTyr mimetic reported to date. To further assess the difluoromethylenesulfonic acid (DFMS) group as a monoanionic phosphate mimetic, a series of 24 nonpeptidyl biaryl compounds bearing the DFMS group were prepared using polymer-supported methodologies and screened for PTP 1B inhibition. Several of these compounds were selected for further study and their IC50's compared to their difluoromethylenephosphonic (DFMP) analogues. The differences in IC50's between the DFMS and DFMP non-peptidyl compounds was not as great as with the F(2)Smp- and F(2)Pmp-bearing peptides. Possible reasons for this and its implication to the design of small molecule PTP1B inhibitors is discussed. (C) 2002 Elsevier Science Ltd. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据